医学信息Issue(11)：537-537,1.
新型口服抗凝药用于降低房颤患者脑卒中风险的研究进展
Research Progress of New Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation
金云鹏1
作者信息
- 1. 浙江大学医学院附属义乌医院，浙江 义乌 322000
- 折叠
摘要
Abstract
New oral anticoagulants,including Dabigatran,Apixaban、Rivaroxaban and Edoxaban have been successful proved by four trials including ER-LY、ROCKER、AFARISTOTLE and AF-TIMI 48 as more ef ective drugs to reduce risk of stroke in patients with artrial fibril ation compared with warfarin,and less risk of bleeding. Recent research progress of new oral anticoagulants to reduce risk of stroke in patients with atrial fibril ation are reviewd.关键词
新型口服抗凝药/房颤/脑卒中/华法林Key words
New oral anticoagulants/Atrial fibril ation/Stroke/Warfarin/Bleeding引用本文复制引用
金云鹏..新型口服抗凝药用于降低房颤患者脑卒中风险的研究进展[J].医学信息,2014,(11):537-537,1.
